US · guidance
CMS Pub. 100-18, ch. 6, § 20.3
Coverage of Supplemental Drugs Under Enhanced Alternative Coverage
A Part D sponsor may only include coverage of drugs that would meet the definition of a Part D
drug but for the application of section 20.1 (these are known as “supplemental drugs,” as
provided in chapter 5, section 10.2 of this manual) as a supplemental benefit under enhanced
alternative coverage.
History
(Rev. 18, Issued: 01-15-16, Effective: 01-15-16; Implementation: 01-15-16)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-09-17
- Edition
- iom-2026-09-17
- Content hash
c461f1732a0160c4e498f2879b41edfceec2da71723880c04c81bfeb306f89de
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.